Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy in vivo and in vitro
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exendin-4, a GLP-1 receptor agonist, suppresses diabetic retinopathy
in vivo
and
in vitro
Authors
Keywords
-
Journal
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Volume -, Issue -, Pages 1-10
Publisher
Informa UK Limited
Online
2023-11-03
DOI
10.1080/13813455.2023.2274279
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diabetic retinopathy for the non-ophthalmologist
- (2022) Timothy HM Fung et al. CLINICAL MEDICINE
- GLP-1 and GIP receptor signaling in beta cells – A review of receptor interactions and co-stimulation
- (2022) Ashok Mayendraraj et al. PEPTIDES
- Circ_0001897 regulates high glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-29c-3p/transforming growth factor beta 2 axis
- (2022) Yudan Gong et al. Bioengineered
- Exendin-4 alleviates β-Amyloid peptide toxicity via DAF-16 in a Caenorhabditis elegans model of Alzheimer's disease
- (2022) Xiangwei Song et al. Frontiers in Aging Neuroscience
- GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway
- (2022) Liufeng Wei et al. Journal of Diabetes Research
- A GLP‐1/GLP‐2 receptor dual agonist to treat NASH : Targeting the gut‐liver axis and microbiome
- (2021) Eun Ran Kim et al. HEPATOLOGY
- Screening for diabetic retinopathy: new perspectives and challenges
- (2020) Stela Vujosevic et al. Lancet Diabetes & Endocrinology
- Exendin‐4, a GLP‐1 receptor agonist regulates retinal capillary tone and restores microvascular patency after ischaemia–reperfusion injury
- (2020) Ruyi Zhai et al. BRITISH JOURNAL OF PHARMACOLOGY
- HbA1c Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression
- (2020) M. Angelyn Bethel et al. DIABETES CARE
- TGF-β Serum Levels in Diabetic Retinopathy Patients and the Role of Anti-VEGF Therapy
- (2020) Vincenza Bonfiglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
- (2020) Kuan‐Yu Lin et al. Journal of Diabetes Investigation
- A flibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
- (2019) Francesca Lazzara et al. BIOCHEMICAL PHARMACOLOGY
- Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages
- (2019) Giuseppe Caruso et al. Antioxidants
- Exendin-4 Protects Human Retinal Pigment Epithelial Cells from H2O2-Induced Oxidative Damage via Activation of NRF2 Signaling
- (2019) Renzhe Cui et al. OPHTHALMIC RESEARCH
- Endothelial angiogenesis is directed by RUNX1T1-regulated VEGFA, BMP4 and TGF-β2 expression
- (2017) Ko-Hsun Liao et al. PLoS One
- Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010
- (2016) Janet L. Leasher et al. DIABETES CARE
- Is GLP-1 a hormone: Whether and When?
- (2016) David D'Alessio Journal of Diabetes Investigation
- Exendin-4 alleviates retinal vascular leakage by protecting the blood–retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats
- (2014) Yichao Fan et al. EXPERIMENTAL EYE RESEARCH
- Müller glial cells inhibit proliferation of retinal endothelial cells via TGF-β2 and Smad signaling
- (2014) Yousef Yafai et al. GLIA
- Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema
- (2012) Jie Ding et al. Current Diabetes Reports
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy
- (2012) Rob J. Van Geest et al. Journal of Cell Communication and Signaling
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
- Exenatide: Its position in the treatment of type 2 diabetes
- (2008) B. Guerci et al. ANNALES D ENDOCRINOLOGIE
- Protection of exendin-4 analogue in early experimental diabetic retinopathy
- (2008) Yu Zhang et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started